Literature DB >> 9462660

Efficient in vitro vectorial transport of a fluorescent conjugated bile acid analogue by polarized hepatic hybrid WIF-B and WIF-B9 cells.

P Bravo1, V Bender, D Cassio.   

Abstract

Efficient transport of bile acids, a typical characteristic of hepatocytes, is partially lost in most hepatoma cell lines and in normal hepatocytes after some days in culture. We have tested whether the polarized rat hepatoma-human fibroblast hybrid WIF (hybrids between W138 and Fao cells) cells previously obtained by our group were able to perform vectorial transport of the fluorescent bile acid derivative cholylglycylamidofluorescein (CGamF) towards the bile canaliculi (BC). Four different WIF clones were analyzed. All were well polarized, as shown by the formation of spherical and even tubular BC-like structures and by the restricted localization at the BC, visualized by immunofluorescence, of the apical membrane marker HA4, a possible bile acid carrier. WIF-B and its subclone WIF-B9 were found to accumulate CGamF in 65% to 75% of their BC. This transport was time, temperature, and partly sodium dependent and was inhibited by coincubation with the parental natural bile salt cholylglycine. Dinitrophenyl glutathione, a substrate of the canalicular multispecific organic anion transporter, did not inhibit CGamF canalicular secretion, whereas it greatly impaired the canalicular secretion of a non-bile acid organic anion, fluorescein, generated intracellularly from fluorescein diacetate. Confocal microscopy confirmed the presence of CGamF in the cytoplasm, supporting a transcellular route from medium to BC. In contrast, two other polarized clones exhibited a poor ability (WIF 12-6) or no ability (WIF12-1 TGdelta) to vectorially transport CGamE In conclusion, WIF-B and WIF-B9 exhibit not only structural but also functional polarity, at least as far as vectorial organic anion transport is concerned.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9462660     DOI: 10.1002/hep.510270236

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  7 in total

1.  Knockdown of tight junction protein claudin-2 prevents bile canalicular formation in WIF-B9 cells.

Authors:  Seiichi Son; Takashi Kojima; Catherine Decaens; Hiroshi Yamaguchi; Tatsuya Ito; Masafumi Imamura; Masaki Murata; Satoshi Tanaka; Hideki Chiba; Koichi Hirata; Norimasa Sawada
Journal:  Histochem Cell Biol       Date:  2008-12-16       Impact factor: 4.304

Review 2.  Hepatocyte polarity.

Authors:  Aleksandr Treyer; Anne Müsch
Journal:  Compr Physiol       Date:  2013-01       Impact factor: 9.090

3.  Spheroid culture for enhanced differentiation of human embryonic stem cells to hepatocyte-like cells.

Authors:  Kartik Subramanian; Derek Jason Owens; Ravali Raju; Meri Firpo; Timothy D O'Brien; Catherine M Verfaillie; Wei-Shou Hu
Journal:  Stem Cells Dev       Date:  2013-10-22       Impact factor: 3.272

4.  Deoxycholic acid modulates cell death signaling through changes in mitochondrial membrane properties.

Authors:  Tânia Sousa; Rui E Castro; Sandra N Pinto; Ana Coutinho; Susana D Lucas; Rui Moreira; Cecília M P Rodrigues; Manuel Prieto; Fábio Fernandes
Journal:  J Lipid Res       Date:  2015-09-08       Impact factor: 5.922

Review 5.  Effect of ethanol on pro-apoptotic mechanisms in polarized hepatic cells.

Authors:  Benita L McVicker; Dean J Tuma; Carol A Casey
Journal:  World J Gastroenterol       Date:  2007-10-07       Impact factor: 5.742

6.  Intracellular trafficking of bile salt export pump (ABCB11) in polarized hepatic cells: constitutive cycling between the canalicular membrane and rab11-positive endosomes.

Authors:  Yoshiyuki Wakabayashi; Jennifer Lippincott-Schwartz; Irwin M Arias
Journal:  Mol Biol Cell       Date:  2004-04-30       Impact factor: 4.138

7.  Expression and subcellular localization of aquaporin water channels in the polarized hepatocyte cell line, WIF-B.

Authors:  Sergio A Gradilone; Pamela S Tietz; Patrick L Splinter; Raúl A Marinelli; Nicholas F LaRusso
Journal:  BMC Physiol       Date:  2005-08-18
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.